Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2020

Summary of Significant Accounting Policies

Schedule Of Cash And Cash Equivalents And Short Term Investments

Short-term investments consisted of the following (in thousands):

							Estimated
			Amortization/		Unrealized		Fair
	Cost		Accretion		Gains/(Losses)		Value
March 31, 2020:
Corporate debt securities	$	5,285	$	4	$	—	$	5,289
December 31, 2019:
Corporate debt securities	$	9,284	$	5	$	(4)	$	9,285

Disaggregation of Revenue

OviTex	$	3,239
OviTex PRS		487
Total revenue	$	3,726

Schedule of fair value of assets and liabilities measured on recurring basis

The following fair value hierarchy table presents information about each major category of the Company’s financial assets and liabilities measured at fair value on a recurring basis (in thousands):

	Fair value measurement at reporting date using
	Quoted prices in
	active markets		Significant other		Significant
	for identical		observable		unobservable
	assets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)
March 31, 2020:
Assets:
Cash equivalents – money market fund	$	38,979	$	—	$	—
Short-term investments – corporate debt securities	$	—	$	5,289	$	—
December 31, 2019:
Assets:
Cash equivalents – money market fund	$	34,918	$	—	$	—
Cash equivalents – corporate debt securities	$	—	$	8,850	$	—
Cash equivalents – government agency securities	$	—	$	1,000	$	—
Short-term investments – corporate debt securities	$	—	$	9,285	$	—

Schedule of warrant liability

January 1, 2019	$	1,640
Change in fair value of warrants		(36)
March 31, 2019	$	1,604

Schedule of dilutive securities excluded

	Three months ended March 31,
	2020	2019
Series A redeemable convertible preferred stock	—	911,336
Series B redeemable convertible preferred stock	—	2,570,376
Stock options (including shares subject to repurchase)	1,482,819	516,756
Series B redeemable convertible preferred stock warrants	—	88,556
Common stock warrants	88,556	—
Total	1,571,375	4,087,024